EPISODE · Feb 13, 2024 · 1H 15M
Unlocking Eyegaze: Learning the Mysteries Behind the Machine with Jenn Rubenstein
from First Bite: Fed, Fun, Functional SLP Insights
Guest: Jenn Rubenstein, MS CCC-SLP - Have you ever stood in AWE watching an eye-gaze user navigate their communication device to express joy but were left scratching your head and wondering, “But how does it work?” In this episode, the ladies of “First Bite” are joined by Jenn Rubenstein, MS CCC-SLP, speech-language pathologist and Clinical Account Executive for Eyegaze, to unlock the mysteries behind the machine. Jenn starts with explanations of the anatomy and physiology, transitions into how the device works to “read” the eye, and then offers an explanation of some diagnoses that could prohibit access for a potential user. Jenn concludes the first of her two-part episode by guiding colleagues through a screening tool to determine if they could potentially benefit from an eye gaze communication device.
What this episode covers
Guest: Jenn Rubenstein, MS CCC-SLP - Have you ever stood in AWE watching an eye-gaze user navigate their communication device to express joy but were left scratching your head and wondering, “But how does it work?” In this episode, the ladies of “First Bite” are joined by Jenn Rubenstein, MS CCC-SLP, speech-language pathologist and Clinical Account Executive for Eyegaze, to unlock the mysteries behind the machine. Jenn starts with explanations of the anatomy and physiology, transitions into how the device works to “read” the eye, and then offers an explanation of some diagnoses that could prohibit access for a potential user. Jenn concludes the first of her two-part episode by guiding colleagues through a screening tool to determine if they could potentially benefit from an eye gaze communication device.
NOW PLAYING
Unlocking Eyegaze: Learning the Mysteries Behind the Machine with Jenn Rubenstein
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m